Director · NovaBridge Biosciences · NovaBridge Biosciences — 2025 Employee Share Option (right to buy)
Side
A
Value
—
Shares
1.09M
Price
—
Executed
Jun 29, 2026
Disclosed
Jun 30, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Jun 29 executedJun 30, 2026 disclosed
NBP · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
NovaBridge Biosciences — 2025 Employee Share Option (right to buy)
Ticker
NBP
Shares
1.09M
Price per share
$0
Execution date (reported)
Jun 29, 2026
Owned after transaction
1.09M shares
Days from execution to publication
1
What this establishes
Fu Wei filed this Form 4 reporting a grant or award of NBP on Jun 29, 2026. It became public on Jun 30, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Fu Weicik:0001885756
Issuer
NovaBridge Biosciencescik:0001778016
Revision history · 0
No field has changed since this record was first ingested.
